Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Cefadroxil (Duricef vs Biodroxil)
NCT02479867Phase 1Completed
- Sponsor
- Genuine Research Center
- Start
- Mar 2014
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cefadroxil in bacterial infection (2 arms), sponsored by Genuine Research Center. Primary endpoints: Maximal measured plasma concentration at 12 hours, Area under the plasma concentration-time curve from time zero to time t at 12 hours and 1 more. Started Mar 2014; status: completed.
02
Drugs
cefadroxil
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT02479867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02479867.